Abstract A new biologically active triterpenoid, favolon B (1), was isolated from fermentation broths of Mycena sp. strain 96180. Favolon B showed antifungal activities towards Botrytis cinerea, Mucor miehei, Paecilomyces variotii and Penicillium notatum. No activities were observed against bacteria and yeasts. The structure of favolon B was elucidated by spectroscopic techniques.
Introduction
In our search of novel and biologically active metabolites from Chilean basidiomycetes, we previously reported four new bioactive compounds, the himanimides, from Serpula himantoides [1] . In the course of further screenings, a new antifungal and cytotoxic triterpenoid, favolon B (1), related to favolon (2) [2] (see Figure 1 for structures), was isolated from fermentations of Mycena sp. strain 96180. This paper describes the fermentation of Mycena sp. strain 96180 and the isolation and chemical as well as biological characterization of favolon B.
Results and Discussion
Mycena 96180 was found on endemic forest soil from Contulmo, near to Concepción, Chile. Mycelial cultures were produced from spore prints of fruiting bodies, which were then grown in a YMG medium composed of yeast extract 0.4%, malt extract 1%, glucose 0.4%, and agar 1.5%, pH 5.5. Small sections of the stock culture were cut under sterile conditions and transferred to a 5-liter Erlenmeyer flask containing 2500 ml of YMG. This flask was incubated at 22°C on a rotary shaker (120 rpm). After 20 days of fermentation, the culture broth was extracted with EtOAc (2.5 liters). Evaporation of the organic phase yielded a crude extract (915 mg), which was applied onto a column containing silica gel (Merck 60, 0.063ϳ0.2 m m; column 3ϫ30 cm). Elution with ethyl acetate : methanol (3 : 7) yielded 33 mg of an enriched product containing the active compound 1.
Final purification was achieved by preparative HPLC (Jasco model PU-980 with a diode array detector; column: Macherey and Nagel, 250ϫ21.2 mm containing 7 m m Nucleosil C18, flow rate: 5 ml/minute). Elution with watermethanol gradient 23 : 77 v/v yielded 11 mg of compound (1).
The structure was elucidated by spectra of 1 The elemental composition suggested by the high resolution MS data show that the molecule has 9 unsaturations, and with one carbon -carbon double bond and three carbonyl groups (suggested by the 1D NMR data) the compound should consequently be pentacyclic. The basic steroid structure could be established by the COSY and HMBC correlations (in C 6 D 6 ), for example the HMBC correlations from 28-H 3 to C-1, C-5, C-9 and C-10, from 27-H 3 to C-12, C-13, C-14 and C-17, from 26-H 3 to C-17, C-18 and C-19, from 6-H, 8-H and 14-H to C-7, from 12-H 2 to C-9 and C-11, and from 8-H to C-9. The position of the ester group is shown by the HMBC correlation from 
Aspergillus ochraceus 8di 15di 20di
Botrytis cinerea 20 24 42
Cladosporium cladosporoides ---
Mucor miehei 15 17 22
Nematospora coryli ---
Paecilomyces varioti 20 25 30
Penicillium islandicum ---
P. notatum 10 12 18
Pythium ultimum ---
Rhodotorula glutinis ---
Saccharomyces cerevisiae is 1** ---
Zygorhynchus moelleri ---
The assays for antimicrobial [3] and cytotoxic activities [4] were carried out towards HL-60 (ATCC CCL 240) and Colon 320 (DSMZ ACC-144) cells. The incorporation of the precursors [2- 14 C thymidine into DNA, 2-14 C uridine into RNA, and 1-14 C leucine into proteins] was assayed with HL-60 cells [5] .
The compound's antifungal and antibacterial activities are compared in Table 2 . Flavolon B (1) exhibits higher antifungal activities towards Botrytis cinerea, Mucor miehei, Paecilomyces variotii, and Penicillium notatum. No antibiotic activities were observed against bacteria and yeasts.
Favolon B (1) also showed moderate cytotoxic activity towards HL-60 (ATCC CCL 240), with IC 50 's of 10 mg/ml, whereas lower cytotoxic effects (25 mg/ml) were observed with Colon 320 (DSMZ ACC-144) cells. The incorporation of 14 C-labelled precursors into macromolecules in HL-60 showed a preferential inhibition of RNA and protein biosynthesis starting from 5ϳ10 mg/ml (Fig. 2) .
Favolon B (1) differs from favolon (2) due to the presence of a double bond in the B ring, which replaces the original favolon's epoxide-group. The structure of favolon B is confirmed by the presence of the proton C-6 in the 1 H NMR as a singlet at 5.65.
This difference apparently confers a selective and reduced spectrum of sensitive fungal strains and positive cytotoxic activities. It is interesting to note that the only active compound produced by Mycena sp. strain 96180 was favolon B and not the antifungal compounds strobilurins and/or oudemansins, the typical active substances of the Mycena genus [6] .
This compound is probably ecologically significant in nature, where the Mycena species uses the isopentyl pyrophosphate pathway, an alternative pathway to shikimic acid, thereby producing favolon B, an antifungal compound that gives the species competitive advantages against potential competitors [7] .
